Market Overview - The Shanghai Composite Index rose by 0.01% to close at 3402.66 points, with a daily high of 3408.2 points [1] - The Shenzhen Component Index fell by 0.11% to close at 10234.33 points, with a daily high of 10263.46 points [1] - The ChiNext Index increased by 0.26% to close at 2067.15 points, with a daily high of 2076.84 points [1] ETF Market Performance - The median return of stock ETFs was 0.0% yesterday, with the highest return from the Ping An Guozheng 2000 ETF at 1.5% [2] - The highest performing industry index ETF was the China Merchants CSI Hong Kong-Shenzhen 500 Healthcare ETF, with a return of 2.32% [2] - The thematic index ETF with the highest return was the China Tai CSI Hong Kong-Shenzhen Innovative Drug Industry ETF, achieving a return of 4.39% [2] ETF Gain and Loss Rankings - The top three ETFs by gain were: - Guotai CSI Hong Kong-Shenzhen Innovative Drug Industry ETF (4.39%) - Tianhong Hang Seng Hong Kong-Shenzhen Innovative Drug Selected 50 ETF (4.02%) - Fortune CSI Hong Kong-Shenzhen Innovative Drug Industry ETF (4.01%) [4] - The top three ETFs by loss were: - Huaxia CSI Selected 500 Growth Innovation Strategy ETF (-1.94%) - Penghua CSI Wine ETF (-1.75%) - Wanji CSI Semiconductor Materials and Equipment Thematic Trading ETF (-1.69%) [4] ETF Fund Flow - The top three ETFs by fund inflow were: - Penghua CSI Wine ETF (4.16 billion yuan) - Huaxia Shanghai Stock Exchange Sci-Tech Innovation Board 50 Component ETF (3.05 billion yuan) - Guolian An CSI All Index Semiconductor Products and Equipment ETF (3.0 billion yuan) [6] - The top three ETFs by fund outflow were: - E Fund ChiNext ETF (5.0 billion yuan) - E Fund CSI 300 ETF Initiated (4.03 billion yuan) - Huashan ChiNext 50 ETF (2.19 billion yuan) [6] ETF Margin Trading Overview - The top three ETFs by margin buying were: - Huaxia Shanghai Stock Exchange Sci-Tech Innovation Board 50 Component ETF (397 million yuan) - Guotai CSI All Index Securities Company ETF (189 million yuan) - E Fund CSI 300 Healthcare ETF (167 million yuan) [8] - The top three ETFs by margin selling were: - Southern CSI 500 ETF (23.09 million yuan) - Huatai Baichuan CSI 300 ETF (15.86 million yuan) - GF CSI 1000 ETF (14.85 million yuan) [9] Institutional Insights - Jianghai Securities highlighted that the Chinese innovative drug sector is entering a "Deep Seek moment," showcasing advantages in clinical research costs and leading-edge technologies, suggesting a convergence of opportunities [10] - Founder Securities noted that the systematic valuation increase in the innovative drug sector is driven by the recognition of the business models of Chinese innovative drug companies [11]
创新药相关ETF领涨，机构称中国创新药企商业模式获认可丨ETF基金日报
2 1 Shi Ji Jing Ji Bao Dao·2025-06-13 05:13